Sophie Lestavel
Lestavel, Sophie
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 188615059 (Personal)
Permalink: http://viaf.org/viaf/188615059
Preferred Forms
-
100 1 _
‡a
Lestavel, Sophie
-
100 0 _
‡a
Sophie Lestavel
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology. |
|
| Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects |
|
| Characterization of the visual phenotype of a mouse model deficient for the FATP1 protein. |
|
| Daily melatonin supplementation in mice increases atherosclerosis in proximal aorta |
|
| Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor |
|
| Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates. |
|
| Étude de la barrière intestinale dans un modèle murin de stéatohépatite non alcoolique (NASH) |
|
| Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity |
|
| Ffar2 expression regulates leukaemic cell growth in vivo. |
|
| Food-Derived Hemorphins Cross Intestinal and Blood-Brain Barriers In Vitro. |
|
| A High Concentration of Melatonin Inhibits In Vitro LDL Peroxidation But Not Oxidized LDL Toxicity Toward Cultured Endothelial Cells |
|
| High-density-lipoprotein subfraction 3 interaction with glycosylphosphatidylinositol-anchored proteins. |
|
| Human free apolipoprotein A-I and artificial pre-beta-high-density lipoprotein inhibit eNOS activity and NO release. |
|
| Immunological and functional properties of in vitro oxidized low density lipoprotein |
|
| Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans. |
|
| Intestinal bile acid receptors are key regulators of glucose homeostasis |
|
| Intestinal role and beyond cholesterol metabolism of PCSK9. |
|
| Intestine-specific regulation of PPARalpha gene transcription by liver X receptors |
|
| Lipid free apolipoprotein E binds to the class B Type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins |
|
| Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1. |
|
| Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin |
|
| Mutation screening of the LDLR gene and ApoB gene in patients with a phenotype of familial hypercholesterolemia and normal values in a functional LDL receptor/apolipoprotein B assay |
|
| Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine |
|
| The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis |
|
| The nuclear receptor FXR in enteroendocrine L cells : regulator of the response to short-chain fatty acids, gut microbiota-metabolites. |
|
| P-glycoprotein and cytochrome P450 3A4 involvement in risperidone transport using an in vitro Caco-2/TC7 model and an in vivo model |
|
| Peroxisome proliferator-activated receptor alpha reduces cholesterol esterification in macrophages |
|
| PPARβ/δ activation induces enteroendocrine L cell GLP-1 production |
|
| Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment |
|
| Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. |
|
| Régulation de l'homéostasie du cholestérol par les récepteurs nucléaires PPARα et LXR dans les macrophages primaires humains |
|
| Retrograde cholesterol transport in the human Caco-2/TC7 cell line: a model to study trans-intestinal cholesterol excretion in atherogenic and diabetic dyslipidemia |
|
| Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver |
|
| Rôle du facteur de transcription E2f1 dans la fonction et l'identité de la cellule bêta pancréatique et identification des mécanismes moléculaires |
|
| Rôle du récepteur nucléaire FXR dans la régulation de la production de GLP-1 : nouvelle cible thérapeutique dans le traitement du diabète de type 2 ? |
|
| Role of Serum Amyloid A During Metabolism of Acute-Phase HDL by Macrophages |
|
| Role of the intestinal Farnesoid X Receptor in gut immune function in the pathophysiological context of non-alcoholic steatohepatitis. |
|
| Roux-en-Y gastric bypass increases systemic but not portal bile acid concentrations by decreasing hepatic bile acid uptake in minipigs |
|
| The RXR Agonist Bexarotene Improves Cholesterol Homeostasis and Inhibits Atherosclerosis Progression in a Mouse Model of Mixed Dyslipidemia |
|
| SR-BI does not require raft/caveola localisation for cholesteryl ester selective uptake in the human adrenal cell line NCI-H295R. |
|
| Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction. |
|
| Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance |
|
| What changes in intestinal functions occurs when obesity is complicated by metabolic diseases? : some elements of answer by the study of the intestinal transcriptome of severely obese patients of the ABOS cohort. |
|
